The Effect of Selective Oxytocin Receptor Inhibitors on Endometriosis-related Pain

Summary

A pilot study to investigate the potential role of atosiban, a selective oxytocin receptor inhibitor, in the management of endometriosis-related pain. Ten patients will be administered atosiban intravenously during 6 hours on a day during their period when they experience (severe) pain

Timeline

Start

2022-02-01

Primary completion

2022-06-01

Completion

2022-07-01

Drugs

Indications